Back to search

Article

Comparison of CRISPR/Cas endonucleases for <i>in vivo</i> retinal gene editing

2020-06-09

Abstract excerpt

<h4>ABSTRACT</h4> CRISPR/Cas has opened the prospect of direct gene correction therapy for some inherited retinal diseases. Previous work has demonstrated the utility of adeno-associated virus (AAV) mediated delivery to retinal cells in vivo ; however, with the expanding repertoire of CRISPR/Cas endonucleases, it is not clear which of these are most efficacious for retinal editing in vivo . We sought to compare...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0a8e7f46-7b2b-5ca5-a839-5c159a386e9f
DOI
10.1101/2020.06.09.141705
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparison of CRISPR/Cas endonucleases for <i>in vivo</i> retinal gene editingDOI 10.1101/2020.06.09.141705
Select a neighboring publication to make it the new centre.